Inspire Medical Systems(INSP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

INSP Inspire Medical Systems

未开盘 07-01 16:00:00 EDT

45.46

+0.85

+1.91%

盘后45.46

+0.000.00%

19:53 EDT

最高47.10	最低45.21	成交量134.86万
今开45.21	昨收44.61	日振幅4.24%
总市值13.09亿	流通市值11.36亿	总股本2,880万
成交额6,196万	换手率5.40%	流通股本2,499万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"INSP","market":"US","secType":"STK","nameCN":"Inspire Medical Systems","latestPrice":45.46,"timestamp":1782936000000,"preClose":44.61,"halted":0,"volume":1348624,"hourTrading":{"tag":"盘后","latestPrice":45.46,"preClose":45.46,"latestTime":"19:53 EDT","volume":12311,"amount":559679.01,"timestamp":1782949997621,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.019054023761488487,"floatShares":24986900,"shares":28797307,"eps":4.472515,"marketStatus":"未开盘","change":0.85,"latestTime":"07-01 16:00:00 EDT","open":45.21,"high":47.1,"low":45.21,"amount":61962924.826832,"amplitude":0.042367,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":4.472515,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1782979200000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1525320000000,"exchange":"NYSE","adjPreClose":44.61,"preHourTrading":{"tag":"盘前","latestPrice":44.99,"preClose":44.62,"latestTime":"09:09 EDT","volume":292,"amount":13030.569204,"timestamp":1782911366167,"change":0.37,"changeRate":0.008292,"amplitude":0.008965},"postHourTrading":{"tag":"盘后","latestPrice":45.46,"preClose":45.46,"latestTime":"19:53 EDT","volume":12311,"amount":559679.01,"timestamp":1782949997621,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.815996,"impliedVol":0.9356,"impliedVolPercentile":0.8964},"requestUrl":"/m/hq/s/INSP","defaultTab":"news","newsList":[{"id":"1108826723","title":"Evercore ISI将Inspire Medical Systems评级从“跑赢大盘”下调至“与大市同步”，目标价从55美元大幅削减至40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1108826723","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108826723?lang=zh_cn&edition=full","pubTime":"2026-06-23 18:20","pubTimestamp":1782210049,"startTime":"0","endTime":"0","summary":"Evercore ISI对Inspire Medical Systems Inc (INSP) 的投资评级进行了调整，将其从原先的“跑赢大盘”下调至“与大市同步”。与此同时，该机构显著调低了该股的目标价，从每股55美元大幅削减至40美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065731478.USD","BK4082","INSP","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149052778","title":"美国银行全球研究下调Inspire Medical Systems评级至\"跑输大盘\"，目标价大幅削减至39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1149052778","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149052778?lang=zh_cn&edition=full","pubTime":"2026-05-22 21:37","pubTimestamp":1779457035,"startTime":"0","endTime":"0","summary":"美国银行全球研究发布最新评级报告，将睡眠呼吸障碍治疗设备公司Inspire Medical Systems的投资评级从\"中性\"大幅下调至\"跑输大盘\"。与此同时，分析师团队将其目标股价从原先的53美元显著调降至39美元，降幅超过26%，显示出对该股未来表现的谨慎预期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","INSP","LU2065731478.USD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159172947","title":"Inspire Medical Systems评级遭下调：Piper Sandler从增持降至中性，目标价从85美元腰斩至55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1159172947","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159172947?lang=zh_cn&edition=full","pubTime":"2026-05-05 22:00","pubTimestamp":1777989609,"startTime":"0","endTime":"0","summary":"医疗设备公司Inspire Medical Systems遭遇投资机构评级下调。Piper Sandler宣布将其投资评级从\"增持\"下调至\"中性\"，同时大幅削减目标股价——从原先的85美元骤降至55美元，降幅超过35%。\n此次调整反映出市场对该公司短期增长前景的谨慎态度。分析师指出，尽管Inspire Medical Systems在睡眠呼吸暂停治疗领域具备技术优势，但当前估值水平已充分反映其增长潜力。目标价的大幅下调预示着机构对其未来盈利能力的预期有所降温。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INSP","BK4167","LU2065731478.USD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190817457","title":"Inspire Medical Systems评级遭美银全球研究下调至中性 目标价腰斩至53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1190817457","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190817457?lang=zh_cn&edition=full","pubTime":"2026-05-05 18:23","pubTimestamp":1777976592,"startTime":"0","endTime":"0","summary":"美银全球研究近日将Inspire Medical Systems的投资评级从\"买入\"下调至\"中性\"，同时大幅调降其目标价，从120美元削减至53美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INSP","LU2065731478.USD","BK4082","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111339875","title":"异动解读 | 多家投行下调目标价，Inspire Medical Systems盘前大跌18.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1111339875","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111339875?lang=zh_cn&edition=full","pubTime":"2026-05-05 16:07","pubTimestamp":1777968451,"startTime":"0","endTime":"0","summary":"Inspire Medical Systems(INSP)今日盘前股价大跌18.6%，引发了市场的广泛关注。消息面上，多家华尔街投行在同一天下调了该公司的目标价。摩根大通将目标价从67美元下调至54美元，Leerink Partners将目标价从78美元下调至52美元，RBC将目标价从56美元下调至45美元，Truist Securities将目标价从64美元下调至50美元。分析师集体下调目标价通常反映了对公司未来增长前景或财务状况的担忧，这直接影响了投资者的信心，导致盘前交易中出现显著的抛售压力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["INSP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167033828","title":"财报前瞻｜Inspire Medical Systems本季度营收预计小幅增长，机构观点偏审慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1167033828","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167033828?lang=zh_cn&edition=full","pubTime":"2026-04-27 10:40","pubTimestamp":1777257609,"startTime":"0","endTime":"0","summary":"Inspire Medical Systems将于2026年05月04日发布财报，市场预期本季度营收温和增长，但利润与EPS指标或承压。公司上季度营收2.69亿美元，同比增长12.25%；毛利率86.59%；归属于母公司股东的净利润1.36亿美元，净利率50.58%，均为同比口径；调整后每股收益1.62美元，同比增长40.87%。目前公开观点整体偏审慎占比更高，理由集中在短期利润与EPS的不确定性。多家机构认为，市场对本季度营收的温和增长已有共识，但费用投放、手术节奏与报销审批等因素可能导致EBIT与EPS阶段性承压。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻｜Inspire Medical Systems本季度营收预计小幅增长，机构观点偏审慎","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INSP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614040277","title":"Inspire Medical Systems旗下医用耗材类产品获FDA批准，注册证号为P130008 S133","url":"https://stock-news.laohu8.com/highlight/detail?id=2614040277","media":"动脉网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614040277?lang=zh_cn&edition=full","pubTime":"2026-02-25 16:27","pubTimestamp":1772008020,"startTime":"0","endTime":"0","summary":"产品名称：QMR Battery Separator Supplier，所属单位：Inspire Medical Systems，产品类型：医用耗材，产品详情：该产品是一种电池隔膜。审批机构：FDA，证件类型：三类，注册证编号：P130008 S133，获批时间：2026-01-30","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225162825a71d5412&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225162825a71d5412&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065731478.USD","BK4167","INSP","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612260349","title":"Inspire Medical Systems, Inc.盘中异动 早盘急速下挫5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612260349","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612260349?lang=zh_cn&edition=full","pubTime":"2026-02-19 23:54","pubTimestamp":1771516465,"startTime":"0","endTime":"0","summary":"北京时间2026年02月19日23时54分，Inspire Medical Systems, Inc.股票出现异动，股价快速下挫5.07%。Inspire Medical Systems, Inc.股票所在的医疗器械行业中，整体跌幅为1.10%。其相关个股中，拜尔德医疗、Modular Medical, Inc.、艾里德克斯涨幅较大，Profusa, Inc.、Bluejay Diagnostics, Inc.、Envue Medical, Inc.较为活跃，换手率分别为41.29%、24.44%、17.69%，振幅较大的相关个股有Strata Skin Sciences, Inc.、拜尔德医疗、Profusa, Inc.，振幅分别为33.72%、31.16%、14.12%。Inspire Medical Systems, Inc.公司简介：Inspire Medical Systems Inc是一家医疗技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260219235425a70aa9e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260219235425a70aa9e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065731478.USD","BK4082","BK4167","INSP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197390221","title":"异动解读 | 多家投行下调目标价，Inspire Medical Systems盘前大跌12.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=1197390221","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197390221?lang=zh_cn&edition=full","pubTime":"2026-02-12 17:45","pubTimestamp":1770889523,"startTime":"0","endTime":"0","summary":"Inspire Medical Systems（INSP）今日盘前股价大幅下挫12.30%，引发了市场的广泛关注。消息面上，多家华尔街知名投行于同日集中下调了该公司的目标价。具体来看，杰富瑞将目标价从81美元下调至66美元，摩根大通将目标价从118美元下调至67美元，Leerink Partners将目标价从127美元下调至78美元，加拿大皇家银行则将目标价从90美元下调至68美元。分析师集中下调目标价通常反映了对公司未来业绩或行业前景的谨慎看法，这一系列负面评级调整被认为是导致该股盘前遭遇抛售、股价显著下跌的主要原因。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["INSP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139728633","title":"异动解读 | 多家投行下调目标价，Inspire Medical Systems夜盘大跌10.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=1139728633","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139728633?lang=zh_cn&edition=full","pubTime":"2026-02-12 15:31","pubTimestamp":1770881461,"startTime":"0","endTime":"0","summary":"Inspire Medical Systems（INSP）今日夜盘股价大幅下挫10.85%，引发市场关注。消息面上，多家华尔街知名投行于同日下调了该公司的目标价。具体来看，杰富瑞将目标价从81美元下调至66美元，摩根大通将目标价从118美元下调至67美元，Leerink Partners将目标价从127美元下调至78美元，加拿大皇家银行则将目标价从90美元下调至68美元。分析师集中下调目标价通常反映了对公司未来业绩或行业前景的谨慎看法，这一系列负面评级调整被认为是导致该股夜盘遭遇抛售、股价显著下跌的主要原因。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["INSP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121404005","title":"财报前瞻｜Inspire Medical Systems本季度营收预计增11.94%，机构观点偏谨慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1121404005","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121404005?lang=zh_cn&edition=full","pubTime":"2026-02-04 11:05","pubTimestamp":1770174316,"startTime":"0","endTime":"0","summary":"Inspire Medical Systems将在2026年02月11日发布财报，市场关注营收与盈利修复节奏及毛利率维持高位的可能性。公司此前财报口径显示毛利率高位运行，上季度毛利率为85.85%，净利率为4.42%，市场据此推演本季度毛利率有望维持相近水平。美国市场仍是Inspire Medical Systems的主要收入来源，预计本季度受医院与手术中心覆盖面扩大带动，新增装机与手术量将贡献增量营收。近期机构对Inspire Medical Systems的观点偏谨慎，关注费用端压力与盈利修复斜率。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻｜Inspire Medical Systems本季度营收预计增11.94%，机构观点偏谨慎","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INSP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176170245","title":"Inspire Medical Systems评级遭RBC下调：从“跑赢大盘”降至“与板块持平”，目标价大幅削减至90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1176170245","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176170245?lang=zh_cn&edition=full","pubTime":"2026-01-27 14:29","pubTimestamp":1769495360,"startTime":"0","endTime":"0","summary":"加拿大皇家银行资本市场（RBC Capital Markets）近日发布研究报告，将Inspire Medical Systems的投资评级从“跑赢大盘”下调至“与板块持平”。同时，该机构将其目标股价从175美元大幅调降至90美元，降幅接近50%。\n此次评级调整反映出分析师对该公司短期增长前景的谨慎态度。目标价的大幅下调可能源于对医疗器械市场竞争加剧、患者植入量增速放缓或医保政策变化的担忧。尽管Inspire Medical Systems在阻塞性睡眠呼吸暂停治疗领域具有技术优势，但当前估值水平需要更扎实的业绩支撑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INSP","BK4167","LU2065731478.USD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191260134","title":"Truist证券下调Inspire Medical Systems评级至持有，目标价降至96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1191260134","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191260134?lang=zh_cn&edition=full","pubTime":"2026-01-23 13:11","pubTimestamp":1769145070,"startTime":"0","endTime":"0","summary":"Truist证券宣布将Inspire Medical Systems的股票评级从“买入”下调至“持有”，同时将其目标股价从120美元大幅削减至96美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","INSP","LU2065731478.USD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138251101","title":"Inspire Medical Systems公司公布2025年第四季度及全年初步未审计营收数据，并发布2026年初步营收指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1138251101","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138251101?lang=zh_cn&edition=full","pubTime":"2026-01-12 19:45","pubTimestamp":1768218320,"startTime":"0","endTime":"0","summary":"Inspire Medical Systems公司近日披露了2025财年第四季度及全年未经审计的初步营收业绩，同时首次给出2026财年的营收展望。最新数据显示，这家专注于创新医疗解决方案的企业在报告期内保持稳健增长态势，其核心产品市场渗透率持续提升。公司管理层表示，2026年的营收预期反映了对睡眠呼吸暂停治疗领域长期增长潜力的信心，未来将通过扩大临床证据基础和拓展全球市场来巩固行业领先地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","LU2065731478.USD","INSP","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514331551","title":"Inspire Medical Systems, Inc.盘中异动 大幅跳水5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514331551","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514331551?lang=zh_cn&edition=full","pubTime":"2025-02-28 03:14","pubTimestamp":1740683651,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日03时14分，Inspire Medical Systems, Inc.股票出现波动，股价急速下跌5.04%。Inspire Medical Systems, Inc.股票所在的医疗器械行业中，整体跌幅为0.18%。其相关个股中，Pavmed Inc C/Wts 30/04/2025 Class Z、Lensar, Inc.、Rapid Micro Biosystems, Inc.涨幅较大，Bone Biologics Corp、Reshape Lifesciences, Inc.、Tandem Diabetes Care, Inc.较为活跃，换手率分别为29.03%、17.12%、13.85%，振幅较大的相关个股有Nexalin Technology Inc C/Wts 、Ainos Inc C/Wts 29/07/2027 、Dih Holdings Us Inc C/Wts 20/04/2028 ，振幅分别为58.93%、53.33%、45.71%。Inspire Medical Systems, Inc.公司简介：Inspire Medical Systems Inc是一家医疗技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280314119632e58d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280314119632e58d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065731478.USD","BK4082","BK4167","INSP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514869254","title":"Inspire Medical Systems, Inc.盘中异动 快速上涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514869254","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514869254?lang=zh_cn&edition=full","pubTime":"2025-02-27 02:36","pubTimestamp":1740594979,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日02时36分，Inspire Medical Systems, Inc.股票出现异动，股价急速上涨5.05%。Inspire Medical Systems, Inc.股票所在的医疗器械行业中，整体涨幅为0.65%。其相关个股中，Bone Biologics Corp C/Wts 13/10/2026 、Biomerica, Inc.、Sight Sciences, Inc.涨幅较大，Venus Concept Inc.、Sintx Technologies, Inc.、Reshape Lifesciences, Inc.较为活跃，换手率分别为22.43%、20.32%、18.04%，振幅较大的相关个股有Pavmed Inc C/Wts 30/04/2025 Class Z、Inogen, Inc、Nexalin Technology Inc C/Wts ，振幅分别为44.00%、38.87%、38.28%。Inspire Medical Systems, Inc.公司简介：Inspire Medical Systems Inc是一家医疗技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227023620a2552e58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227023620a2552e58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","LU2065731478.USD","BK4167","INSP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514177418","title":"Inspire Medical Systems, Inc.盘中异动 股价大涨5.24%报186.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514177418","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514177418?lang=zh_cn&edition=full","pubTime":"2025-02-25 01:58","pubTimestamp":1740419916,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日01时58分，Inspire Medical Systems, Inc.股票出现波动，股价急速拉升5.24%。截至发稿，该股报186.62美元/股，成交量17.2906万股，换手率0.58%，振幅5.89%。Inspire Medical Systems, Inc.股票所在的医疗器械行业中，整体涨幅为0.90%。Inspire Medical Systems, Inc.公司简介：Inspire Medical Systems Inc是一家医疗技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225015836962ec446&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225015836962ec446&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INSP","LU2065731478.USD","BK4082","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511692153","title":"Inspire Medical Systems, Inc.2024财年实现净利润53.51百万美元，同比增加353.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511692153","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511692153?lang=zh_cn&edition=full","pubTime":"2025-02-15 00:00","pubTimestamp":1739548832,"startTime":"0","endTime":"0","summary":"2月15日，Inspire Medical Systems, Inc.公布财报，公告显示公司2024财年净利润为53.51百万美元，同比增加353.00%；其中营业收入为8.03亿美元，同比增加28.48%，每股基本收益为1.80美元。从资产负债表来看，Inspire Medical Systems, Inc.总负债1.19亿美元，其中短期债务1.75百万美元，资产负债比为6.79，流动比率为0.08。机构评级：截至2025年2月15日，当前有16家机构对Inspire Medical Systems, Inc.目标价做出预测，其中目标均价为235.88美元，其中最低目标价为190.00美元，最高目标价为280.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215000040a246150a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215000040a246150a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INSP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510330098","title":"Truist Securities：维持Inspire Medical Systems(INSP.US)评级，由买入调整至买入评级, 目标价由250.00美元调整至235.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2510330098","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510330098?lang=zh_cn&edition=full","pubTime":"2025-02-12 01:52","pubTimestamp":1739296377,"startTime":"0","endTime":"0","summary":"Truist Securities：维持Inspire Medical Systems(INSP.US)评级，由买入调整至买入评级, 目标价由250.00美元调整至235.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/12015248092604.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["INSP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196489174","title":"异动解读 | Inspire Medical Systems股价大跌6.06%,机构下调评级或目标价或为主因","url":"https://stock-news.laohu8.com/highlight/detail?id=1196489174","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196489174?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:48","pubTimestamp":1739285319,"startTime":"0","endTime":"0","summary":"Inspire Medical Systems股价今日盘中大跌6.06%,引发了市场的广泛关注。从目前可获取的相关新闻来看,该股下跌的主要原因可能是部分机构对其发表了负面评级或目标价调整。数据显示,富国银行维持了对Inspire Medical Systems的\"持股观望\"评级,但将其目标价从198美元调整至195美元,可能反映了分析师对该股前景的小幅负面评估。总的来说,虽然Inspire Medical Systems并无重大利空消息,但因机构下调该股评级或目标价,市场情绪显现出不确定性,从而导致这一股价大幅下挫的情况出现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | Inspire Medical Systems股价大跌6.06%,机构下调评级或目标价或为主因","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["INSP"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.inspiresleep.com","stockEarnings":[{"period":"1week","weight":0.0685},{"period":"1month","weight":0.0786},{"period":"3month","weight":-0.1683},{"period":"6month","weight":-0.5163},{"period":"1year","weight":-0.6562},{"period":"ytd","weight":-0.5163}],"compareEarnings":[{"period":"1week","weight":0.018},{"period":"1month","weight":-0.0128},{"period":"3month","weight":0.1397},{"period":"6month","weight":0.0951},{"period":"1year","weight":0.2087},{"period":"ytd","weight":0.0951}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Inspire Medical Systems, Inc.于2007年11月在特拉华州注册成立。该公司是一家医疗技术公司，专注于为阻塞性睡眠呼吸暂停（OSA）患者开发和商业化创新的微创解决方案。该公司专有的Inspire系统是第一个也是唯一一个获得FDA批准的神经刺激技术，可为中度至重度OSA提供安全有效的治疗。该公司开发了一种新颖的闭环解决方案，可持续监测患者的呼吸，并提供轻微的舌下神经刺激，以维持开放的气道。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.027154},{"month":2,"riseRate":0.625,"avgChangeRate":0.031099},{"month":3,"riseRate":0.25,"avgChangeRate":-0.085412},{"month":4,"riseRate":0.625,"avgChangeRate":0.049509},{"month":5,"riseRate":0.375,"avgChangeRate":-0.091314},{"month":6,"riseRate":0.666667,"avgChangeRate":0.036431},{"month":7,"riseRate":0.625,"avgChangeRate":0.063153},{"month":8,"riseRate":0.625,"avgChangeRate":0.051217},{"month":9,"riseRate":0.375,"avgChangeRate":-0.058537},{"month":10,"riseRate":0.25,"avgChangeRate":-0.028609},{"month":11,"riseRate":0.625,"avgChangeRate":0.204272},{"month":12,"riseRate":0.625,"avgChangeRate":0.019281}],"exchange":"NYSE","name":"Inspire Medical Systems","nameEN":"Inspire Medical Systems"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Inspire Medical Systems(INSP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Inspire Medical Systems(INSP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Inspire Medical Systems,INSP,Inspire Medical Systems股票,Inspire Medical Systems股票老虎,Inspire Medical Systems股票老虎国际,Inspire Medical Systems行情,Inspire Medical Systems股票行情,Inspire Medical Systems股价,Inspire Medical Systems股市,Inspire Medical Systems股票价格,Inspire Medical Systems股票交易,Inspire Medical Systems股票购买,Inspire Medical Systems股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Inspire Medical Systems(INSP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Inspire Medical Systems(INSP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}